These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 7931827)
1. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. Baas IO; Mulder JW; Offerhaus GJ; Vogelstein B; Hamilton SR J Pathol; 1994 Jan; 172(1):5-12. PubMed ID: 7931827 [TBL] [Abstract][Full Text] [Related]
2. p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers. Costa A; Marasca R; Valentinis B; Savarino M; Faranda A; Silvestrini R; Torelli G J Pathol; 1995 May; 176(1):45-53. PubMed ID: 7616356 [TBL] [Abstract][Full Text] [Related]
3. Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry. Bonsing BA; Corver WE; Gorsira MC; van Vliet M; Oud PS; Cornelisse CJ; Fleuren GJ Cytometry; 1997 May; 28(1):11-24. PubMed ID: 9136751 [TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas. Campo E; de la Calle-Martin O; Miquel R; Palacin A; Romero M; Fabregat V; Vives J; Cardesa A; Yague J Cancer Res; 1991 Aug; 51(16):4436-42. PubMed ID: 1868464 [TBL] [Abstract][Full Text] [Related]
5. Expression of p53 and 17p allelic loss in colorectal carcinoma. Cunningham J; Lust JA; Schaid DJ; Bren GD; Carpenter HA; Rizza E; Kovach JS; Thibodeau SN Cancer Res; 1992 Apr; 52(7):1974-80. PubMed ID: 1551126 [TBL] [Abstract][Full Text] [Related]
6. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas. Helland A; Holm R; Kristensen G; Kaern J; Karlsen F; Trope C; Nesland JM; Børresen AL J Pathol; 1993 Oct; 171(2):105-14. PubMed ID: 8283348 [TBL] [Abstract][Full Text] [Related]
7. Immunohistological p53 staining is of limited value in the staging and prognostic prediction of colorectal cancer. Kressner U; Lindmark G; Gerdin B; Påhlman L; Glimelius B Anticancer Res; 1996; 16(2):951-7. PubMed ID: 8687158 [TBL] [Abstract][Full Text] [Related]
8. Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasms. Baas IO; van den Berg FM; Mulder JW; Clement MJ; Slebos RJ; Hamilton SR; Offerhaus GJ J Pathol; 1996 Mar; 178(3):264-7. PubMed ID: 8778330 [TBL] [Abstract][Full Text] [Related]
9. Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection. Lambkin HA; Mothersill CM; Kelehan P J Pathol; 1994 Jan; 172(1):13-8. PubMed ID: 7931822 [TBL] [Abstract][Full Text] [Related]
10. [p53 gene mutation in cancer of the colon and rectum]. Roa JC; Roa I; Melo A; Araya JC; Villaseca MA; Flores M; Schneider B Rev Med Chil; 2000 Sep; 128(9):996-1004. PubMed ID: 11349504 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical demonstration of mutant p53 tumour suppressor gene product in aberrant crypt foci. Stopera SA; Bird RP Cytobios; 1993; 73(293):73-88. PubMed ID: 8319499 [TBL] [Abstract][Full Text] [Related]
12. [Immunochemical evidence of a mutated p53 protein expressed in human colorectal adenocarcinoma]. Hammel PR; Beuvon FX; Salmon RJ; Remvikos Y Gastroenterol Clin Biol; 1991; 15(6-7):529-35. PubMed ID: 1916131 [TBL] [Abstract][Full Text] [Related]
14. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma. Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234 [TBL] [Abstract][Full Text] [Related]
15. A frequent alteration of p53 gene in carcinoma in adenoma of colon. Ohue M; Tomita N; Monden T; Fujita M; Fukunaga M; Takami K; Yana I; Ohnishi T; Enomoto T; Inoue M Cancer Res; 1994 Sep; 54(17):4798-804. PubMed ID: 8062281 [TBL] [Abstract][Full Text] [Related]
16. Expression of p53 and retinoblastoma gene in high-grade nodal peripheral T-cell lymphomas: immunohistochemical and molecular findings suggesting different pathogenetic pathways and possible clinical implications. Pescarmona E; Pignoloni P; Santangelo C; Naso G; Realacci M; Cela O; Lavinia AM; Martelli M; Russo MA; Baroni CD J Pathol; 1999 Aug; 188(4):400-6. PubMed ID: 10440751 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of mutant p53 oncogene in transitional mucosa adjacent to human colon cancer. Baytner S; Mitmaker B; Gordon PH; Wang E Clin Invest Med; 1993 Oct; 16(5):379-85. PubMed ID: 8261691 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of p53 protein in archival tissues from squamous cell carcinomas of the oral cavity using wet autoclave antigen retrieval. Piffko J; Bankfalvi A; Ofner D; Joos U; Böcker W; Schmid KW J Pathol; 1995 May; 176(1):69-75. PubMed ID: 7616359 [TBL] [Abstract][Full Text] [Related]
19. Frequent p53 gene mutations in serrated adenomas of the colorectum. Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies. Bártek J; Bártková J; Lukás J; Stasková Z; Vojtĕsek B; Lane DP J Pathol; 1993 Jan; 169(1):27-34. PubMed ID: 8433213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]